期刊文献+

深圳地区2003-2012年献血者HBsAg/NAT检测结果情况分析 被引量:2

Analysis of HBsAg / NAT test results of the blood donors in Shenzhen city in 2003-2012
原文传递
导出
摘要 目的分析深圳地区2003-2012年期间献血者HBV感染的流行走势情况。方法所有献血者血样均使用进口与国产酶联免疫试剂,以及血液病毒核酸检测(NAT)方法筛查HBsAg和HBV DNA,采用χ2检验进行统计分析献血者感染HBV的流行趋势。结果深圳地区2003-2012年采血量稳步增长,HBsAg阳性检出率总体呈下降趋势,HBsAg+/NAT+与HBsAg+/NAT-检出率结果相当(1.2∶1);献血者中HBsAg-/HBV DNA+阳性率呈升高趋势。不同年龄组献血者HBV感染率差异无统计学意义(P>0.05)。结论酶联免疫与NAT方法为重要的互补检测手段,能进一步确保输血安全,而隐匿性乙型肝炎病毒感染呈升高态势,应引起高度重视。 Objective To study the trend of HBV infection in blood donors in Shenzhen city in 2003-2012. Methods Blood samples were tested using both domestic and imported ELISA reagents along with nucleic acid detection for HBsAg and NAT. The data were analyzed with X2 test using SPSS software. Results Data showed that with the steady growth in the volume of blood donation, positive detection rate of HBsAg declined each year and the detection rate of HBsAg+/NAT+ was basically the same as HBsAg+/NAT- ( 1.2:1 ) ; But positive detection rate of HBV DNA in HBsAg- blood samples was higher than before. After analyzed by SPSS software, we found that the rate of HBV infection showed no significant difference in gender or age, respectively (P〉0.05). Conclusion Our experimental results suggested that we had better use both ELISA and nucleic acid testing to ensure the safety of blood transfusion. Besides, we should pay more attention on the sustainable growth incidence of occult hepatitis B infection.
机构地区 深圳市血液中心
出处 《热带医学杂志》 CAS 2013年第11期1347-1350,共4页 Journal of Tropical Medicine
基金 广东省医学科学技术研究基金(A2012580)
关键词 献血者 酶联免疫 NAT HBSAG 检出率 blood donor ELISA NAT HBsAg detection rate
  • 相关文献

参考文献10

  • 1李莉,惠永庆,樊晶.2006~2010年天津市无偿献血者血液检测结果分析[J].中国输血杂志,2012,25(1):48-49. 被引量:52
  • 2Liang X, Bi S, Yang W, et al. Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination [ J ]. Vaccine, 2009,27 (47) : 6550-6557.
  • 3Seed CR, Kiely P, Keller AJ. Residual risk of transfusion transmitted human immunodeficiency virus,hepatitisB virus, hepatitis C virusand human T lymphotrophic virus [J ]. Inter Med J, 2005,35 (10) : 592-598.
  • 4Shang G,Seed CR,Wang F,et al. Residual risk of transfusion- transmitted viral infections in Shenzhen,China [J]. Transfusion, 2007,47(3) :529-539.
  • 5Fang Y,Shang QL,Liu JY,et al. Prevalence of occult hepatitis B virus infection among hepatopathy patients and healthy people in China[ J ]. J Infect, 2009,58 (5) : 383-388.
  • 6Roth WK, Busch MP, Schuller A, et al. International survey on NAT testing of blood donations:expanding implementation and yield from 1999 to 2009 [ J ]. Vox Sang, 2012,102(6) : 82-90.
  • 7马兰,古醒辉,曾劲峰,曾雪珍,聂冬梅,李雪梅.无偿捐血者HBsAg三种试剂检测结果比较分析[J].热带医学杂志,2011,11(11):1270-1271. 被引量:1
  • 8Ekiaby ME, Lelie N, Allain JP. Nucleic acid testing (NAT) in high prevalence-low resource settings [J]. Biologicals, 2010,38 (5) : 59-64.
  • 9徐秋英,刘亚敏,沈强.362例乙肝患者HBV-DNA含量与免疫学标志物、肝功能关系分析[J].热带医学杂志,2009,9(7):747-749. 被引量:4
  • 10Zheng X, Ye X, Zhang L, et al. Characterization of occult hepatitis B virus infection from blood donors in China [ J ]. J Clin Microbiol, 2011,49(3) : 1730-1737.

二级参考文献17

共引文献54

同被引文献25

  • 1Zheng X,Ye XL,Zhang L,et al.Characterization of occult hepatitis B virus infection from blood donors in China.J Clin Microbiol,2011,49(5):1730-1737.
  • 2Allain JP,Mihaljevic I,Gonzalez-Fraile MI,et al.Infectivity of blood products from donors with occult hepatitis B virus infection.Transfusion.2013,53(7):1405-1415.
  • 3Yuen MF,Wong DK,Lee CK,et al.Transmissibility of hepatitis B virus(HBV)infection through blood transfusion from blood donors with occult HBV infection.Clin Infect Dis,2011,52(5):624-632.
  • 4Candotti D,Grabarczyk P,Ghiazza P,et al.Characterization of occult hepatitis B virus from blood donors carrying genotype A2 or genotype D strains.J Hepatol,2008,49(4):537-547.
  • 5Coleman PF.Detecting hepatitis B surface antigen mutants.Emerg Infect Dis,2006,12(2):198-203.
  • 6Khakoo SI,Ling R,Scott I,et al.Cytotoxic T lymphocyte responses and CTL epitope escape mutation in HBs Ag,anti2HBe+itive indi-viduals1 Gut,2000,47(1):137.
  • 7Yuki N,Nagaoka T,Yamashiro M,et al.Long-term histologic and virologic outcomes of acute self-limited hepatitis B.Hepatology,2003,37(5):1172-1179.
  • 8Candotti D1,Lin CK,Belkhiri D,et al.TOccult hepatitis B infection in blood donors from South East Asia molecular characterisation and potential mechanisms.Gut.,2012,61(12):1744-1753.
  • 9Allain JP,Belkhiri D,Vermeulen M,et al.Characterization of occult hepatitis B virus strains in South African blood donors.Hepatology,2009,49(1):1868-1876.
  • 10Bouchard MJ,Schneider RJ.The enigmatic X gene of hepatitis B virus.J Virol,2004,78(23):12725-12734.

引证文献2

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部